overlay image
All Case Studies Webinar White Papers Expert Content News & Updates Articles Summary Sheets Brochures
Category

Articles

Today's Solid Dose Drugs: High Potency, High Stakes - Pharma Manufacturing

As oral solid dose (OSD) drugs in development become more potent, regulatory expectations keep changing.

Articles

“In Safe Hands” Pharma Tech - 30 year anniversary Q&A

It has been widely reported that the number of highly complex and potent molecules entering development is rising, particularly in lieu of the fact that the bio/pharma industry is leaning towards personalized therapeutic offerings and drug development for orphan diseases.

Articles

EHS is the New GMP - Specialty Chemicals

Kenneth Ball, Commercial Operations Lead at Pfizer CentreOne, sat down with Specialty Chemicals to look at why environmental responsibility is now critical in the pharmaceutical supply chain.

Articles

The Integrated CDMO Q&A with JoyL Silva

Contract Pharma talked with JoyL Silva, general manager at Pfizer CentreOne to unpack some of the benefits the embedded CDMO model offers, small molecule trends in general, as well Pfizer CentreOne’s plans and predictions for future growth.